drugset / Trial / NCT01054092

A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

NCT01054092

Phase 3 Completed 182 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to evaluate the long-term safety of ASP1941 in patients with type 2 diabetes mellitus. The second objectives are to compare the efficacy and pharmacokinetics of ASP1941 administered before or after food intake.

Timeline

Start
2010-01-14
Primary completion
2011-07-22
Completion
2011-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule Oral